In biology, and particularly in renal physiology, there is often a delay between 26 observations of clinically relevant phenomena and elucidation of the underlying 27 mechanisms, because the tools ("hammers") available to researchers are insufficient 28 and require development of new and innovative techniques to overcome these hurdles. 29
The role of insulin action in different tissues is one such phenomenon. Since the work of 30 De Fronzo et. al. (1) , many investigators have tried to tease apart how and if insulin 31 increases blood pressure due to enhanced renal sodium reabsorption and whether this 32 is due to direct or indirect actions on the kidneys, nervous system, or vasculature. In this 33 issue, Irsik et. al. report on a technique to deliver insulin to the intact rat kidney in order 34 to measure its direct effect on renal ion handling and blood pressure. 35
The central role of the kidney in determination of blood pressure has been appreciated 36 since Guyton's recognition of sodium excretion as a critical regulator of blood volume 37 (2). Over the past several decades, many studies in humans have demonstrated strong 38 associations between hypertension and conditions associated with insulin resistance 39 and concomitant hyperinsulinemia (e.g. metabolic syndrome and type 2 diabetes 40 mellitus). Several lines of evidence support the hypothesis that insulin may act in the 41 kidney to increase blood pressure (9). Insulin infusion, dosed to mimic the 42 hyperinsulinemia of insulin resistance, decreases sodium excretion in humans (1) and in 43 many pre-clinical models, and serum insulin concentration associates with higher blood 44 pressure in humans (7). However, efforts to determine the organ and cell types that may 45 transduce insulin's antinatriuretic and possible hypertensive effects have been 46 challenging. To address this issue in rats, Irsik et. al. deliver insulin to the kidney via a 47 microcatheter placed into the renal artery of one kidney after contralateral nephrectomy. 48
The authors demonstrate convincingly that there are negligible systemic effects of the 49 insulin infusion and thus provide an elegant model of enhanced, kidney-restricted insulin 50 signaling without changes in blood glucose. These rats developed increasing blood 51 pressure over one week of chronic infusion surprisingly, without an antecedent decrease 52 in net sodium excretion. 53
This work by Irsik et. al. lays the groundwork for a critical next question: is insulin action 54 in the renal vasculature sufficient to augment blood pressure? Thus far, the role of 55 insulin signaling to augment blood pressure has mainly focused on insulin's ability to 56 augment sodium reabsorption in the nephron but the results have been incongruent. 57
While, several sodium transporters and channels are upregulated in expression or 58 activity with elevated insulin in vivo, ex vivo, and in vitro (7), Tiwari et. al.(10) showed 59 study in rats, and its methodology could be applied in non-nephrectomized rats to study 65 the renal molecular mechanisms of insulin-mediated increased blood pressure. Using 66 unilateral renal hyperinsulinemia, the contralateral kidney would respond to any systemic 67 effects, providing a control for indirect effects of renal insulin infusion (e.g. 68 downregulation of distal sodium transporters or channels if insulin enhances proximal 69 tubular sodium reabsorption). 70
It should be noted that these data contrast previous work in dogs (3), also by Brands and 71 colleagues, in which intrarenal insulin infusion did not alter blood pressure. These data 72 echo the disparate results across species (from mice to humans) which have 73 confounded the field of renal insulin signaling (7). The reasons for these differences arestill unknown. Potential explanations include differences in insulin sensitivity, 75 pharmacokinetics, or compensatory effects of contralateral nephrectomy. 76
An unresolved issue not directly addressed by this important work is the contribution of 77 renal insulin signaling to blood pressure in disease or genetic models characterized by 78 insulin resistance, such as metabolic syndrome and diabetes mellitus. Prior work by this 79 same group have demonstrated that while chronic insulin did not reduce sodium 80 excretion in healthy dogs, diabetic dogs, in response to insulinopenia, experience 81 dramatic sodium excretion that is rescued with insulin treatment (6). In addition, there 82 may be a significant distinction between insulin resistance-mediated compensatory 83 hyperinsulinemia and insulin infusion. For example, our laboratory showed that an 84 increase in epithelial sodium channel activity, measured in several insulin-sensitive 85 mouse models with insulin treatment, was absent in insulin resistant, hyperinsulinemic 86 mice (8). Using the advances in kidney-restricted hyperinsulinemia described in Irsik et. 87 al., this issue could now be addressed in rat models of insulin resistance and 88 hypertension. Moreover, utilizing this technique in transgenic animals is now more 89 tractable than in the aforementioned use of direct renal insulin infusion in dogs. 90
Another intriguing implication of this work is the potential action of insulin on renal 91 insulin-like growth factor 1 (IGF-1) receptors. Although the experiments were conducted 92 quite differently, Tiwari et. al. (10) has provided, and utilization of this technique in disease models will no doubt further 103 elucidate the role of insulin signaling in the kidney. Direct renal infusion can also be 104 adapted to address the actions of other extrarenal hormones with multiple renal and 105 extrarenal sites of action, e.g. glucagon, glucagon-like peptide-1, etc. Perhaps soon this 106 new hammer will find another nail to strike. 107
